George Green, Bristol Myers Squibb

 

George Green joins Beyond the Scope to discuss the pharmaceutical industry's perspective on digital pathology and artificial intelligence. The conversation revolves around how digital pathology will see increased applications in the current era of precision medicine. (posted April 2021)


 

 

Please log in to your DPA profile to submit comments

 

RELATED CONTENT

PODCAST

Global Digital Pathology Task Force

Season 2 Episode 9

LISTEN NOW

PODCAST

Raisa Glabman, NIH NCI CBSTP Fellow

Season 1 Episode 10

LISTEN NOW

PODCAST

Emily Volk, CAP President

Season 3 Episode 10

LISTEN NOW